Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension

PHASE3UnknownINTERVENTIONAL

Enrollment

144

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions

Pulmonary HypertensionSystolic Dysfunction

Interventions

DRUG

Sildenafil

Oral sildenafil 20 mg TID for 12 weeks

DRUG

Placebo

Oral placebo TID for 12 weeks

Trial Locations (1)

RECRUITING

11 institutions including Hallym University Dongtan Sacred Heart Hospital, Seoul